Zionexa Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 24

Employees

  • Latest Deal Type
  • M&A

Zionexa General Information

Description

Developer of molecular imaging technology designed to diagnose metastatic breast cancer. The company's technology provides physicians with new ways to look inside the human body by delivering images of remarkable clarity to identify the disease in its earliest stages and determine the exact location of a tumor, thereby helping doctors to personalize patient care within the framework of new personalized diagnostic approaches

Contact Information

Website
www.zionexa.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 42 Avenue de la Grande Armée
  • 75017 Paris
  • France
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 42 Avenue de la Grande Armée
  • 75017 Paris
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zionexa Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 06-May-2021 Completed Generating Revenue
3. Early Stage VC 11-Apr-2019 Cancelled Generating Revenue
2. Early Stage VC 11-Apr-2019 $5.05M $10.9M Completed Generating Revenue
1. Early Stage VC 19-Sep-2018 $5.81M $5.81M Completed Startup
To view Zionexa’s complete valuation and funding history, request access »

Zionexa Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 2,018,208 $1.128104
To view Zionexa’s complete cap table history, request access »

Zionexa Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of molecular imaging technology designed to diagnose metastatic breast cancer. The company's technology provid
Biotechnology
Paris, France
24 As of 2021

Centennial, CO

Redwood City, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Zionexa Competitors (13)

One of Zionexa’s 13 competitors is Novus Biologicals, a Formerly PE-Backed company based in Centennial, CO.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novus Biologicals Formerly PE-Backed Centennial, CO
Adverum Biotechnologies Formerly VC-backed Redwood City, CA
Kynexis Venture Capital-Backed Naarden, Netherlands
Abcam Corporate Backed or Acquired Cambridge, United Kingdom
Autogenomics Formerly VC-backed Carlsbad, CA
You’re viewing 5 of 13 competitors. Get the full list »

Zionexa Patents

Zionexa Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2545536-T3 Fluoride-18 labeling method of tropane derivatives Inactive 14-Nov-2006
EP-1925615-A1 Method of fluorine-18 labelling of tropane derivatives Active 14-Nov-2006
EP-1925615-B1 Method of fluorine-18 labelling of tropane derivatives Inactive 14-Nov-2006
WO-2008059349-A1 Method of fluorine-18 labelling of tropane derivatives Inactive 14-Nov-2006 C07D451/02

Zionexa Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Zionexa Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Denos Corporation Minority
JEREMIE Auvergne Venture Capital Minority
Sofimac Investment Managers Growth/Expansion Minority
iXO Private Equity PE/Buyout Minority
To view Zionexa’s complete investors history, request access »

Zionexa FAQs

  • When was Zionexa founded?

    Zionexa was founded in 1998.

  • Where is Zionexa headquartered?

    Zionexa is headquartered in Paris, France.

  • What is the size of Zionexa?

    Zionexa has 24 total employees.

  • What industry is Zionexa in?

    Zionexa’s primary industry is Biotechnology.

  • Is Zionexa a private or public company?

    Zionexa is a Private company.

  • What is Zionexa’s current revenue?

    The current revenue for Zionexa is .

  • How much funding has Zionexa raised over time?

    Zionexa has raised $10.9M.

  • Who are Zionexa’s investors?

    Denos, JEREMIE Auvergne, Sofimac Investment Managers, and iXO Private Equity have invested in Zionexa.

  • Who are Zionexa’s competitors?

    Novus Biologicals, Adverum Biotechnologies, Kynexis, Abcam, and Autogenomics are some of the 13 competitors of Zionexa.

  • When was Zionexa acquired?

    Zionexa was acquired on 06-May-2021.

  • Who acquired Zionexa?

    Zionexa was acquired by GE HealthCare Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process